Head-to-head · Cost-Efficiency Index
Go Vida Plena vs NuvaHealth
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Go Vida Plena
Cost-first shoppers who want spanish-speaking patients wanting GLP-1 access with culturally-tailored, Spanish-first support.
Visit Go Vida PlenaNuvaHealth
Shoppers comfortable finding out the real recurring price only at checkout.
Visit NuvaHealthThe verdict
Go Vida Plena and NuvaHealth tie on the Cost-Efficiency Index at 66/100, so neither wins outright on the numbers. For most shoppers we'd start with Go Vida Plena (ranked #147, a hair above #149) — Cost-first shoppers who want spanish-speaking patients wanting GLP-1 access with culturally-tailored, Spanish-first support. But NuvaHealth is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Go Vida Plena.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Go Vida Plena | NuvaHealth |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 66/100 |
| Semaglutide / mo | $179/mo (annual plan, compounded) | $89/mo (starting dose, first-month rate, compounded) |
| Tirzepatide / mo | $269/mo (annual plan, compounded) | $139/mo (starting dose, first-month rate, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $1,068 |
| Tirzepatide / yr (modeled) | $3,228 | $1,668 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #147 | #149 |
Go Vida Plena
66/100Where the value is
- Genuinely bilingual, Spanish-first platform serving an underserved market segment
- Offers both injectable and oral GLP-1 formulations
- Explicit, plain-language disclosure that compounded drugs are not FDA-approved
The tradeoffs
- Lowest advertised prices ($179/$269) require an annual plan commitment, not simple month-to-month billing
- Per-day price framing ('~$6/day') is used on the homepage, a common technique to understate the real monthly cost
NuvaHealth
66/100Where the value is
- LegitScript certified with a working verification badge
- Names four real pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx) rather than one anonymous 'licensed pharmacy'
- All 50 states served per its own FAQ
The tradeoffs
- The headline $89/$139 prices are explicitly first-month-only per NuvaHealth's own FAQ — the real month-two-plus recurring price is not published anywhere and only appears at checkout after intake
- No named prescriber or medical director anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.